Jean Melvin
Psychiatry · Charlotte, NCNPI 1861435208
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.8%), food and beverage and education — rather than concentrated in one kind of arrangement. AbbVie accounts for 63.8% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2019 at $6,765 and has fallen 92.5% since, to $504 in 2024. Among psychiatry clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 292 payments — averaging $35.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$7K
- Sunovion Pharmaceuticals Inc.$813
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$590
- Neurocrine Biosciences, Inc.$353
- Teva Pharmaceuticals USA, Inc.$336
- Takeda Pharmaceuticals U.S.A., Inc.$283
- plus $1K from 15 others
What the payments were for
- Speaking & faculty fees$5,92558%
- Food & beverage$4,22641%
- Education$971%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 90 | $6,542 |
| Sunovion Pharmaceuticals Inc. | 33 | $813 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 34 | $590 |
| Neurocrine Biosciences, Inc. | 9 | $353 |
| Teva Pharmaceuticals USA, Inc. | 34 | $336 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $283 |
| Johnson & Johnson | 16 | $281 |
| Lundbeck LLC | 12 | $200 |
| Eisai Inc. | 5 | $148 |
| Alkermes, Inc. | 9 | $146 |
| Supernus Pharmaceuticals, Inc. | 6 | $100 |
| Merck | 5 | $82 |
| Tris Pharma Inc | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 4 | $58 |
| Bausch Health US, LLC | 4 | $57 |
| Noven Therapeutics, LLC | 3 | $55 |
| Adlon Therapeutics L.p. | 3 | $46 |
| Avanir Pharmaceuticals, Inc. | 2 | $28 |
| Almatica Pharma LLC | 1 | $19 |
| Ironshore Pharmaceuticals Inc. | 1 | $18 |
| Neuronetics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,248 in reported general payments places this provider in the 90th percentile of 1,108 psychiatry providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FetzimaLevomilnacipran Hcl | 20 | $13,547 |
| Lurasidone Hcl | 31 | $6,303 |
| Bupropion XlBupropion Hcl | 98 | $4,455 |
| Duloxetine Hcl | 136 | $3,011 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 23 | $2,305 |
| Lamotrigine | 136 | $2,140 |
| Quetiapine Fumarate | 152 | $2,124 |
| Clonazepam | 183 | $1,948 |
| Escitalopram Oxalate | 104 | $1,439 |
| Vilazodone Hcl | 13 | $1,369 |
| Alprazolam | 204 | $1,329 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 30 | $1,315 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 55 | $1,281 |
| Trazodone Hcl | 122 | $1,249 |
| Alprazolam ErAlprazolam | 26 | $1,126 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieFetzima | $6,542 | $13,54720 claims |
| Almatica Pharma LLCSertraline Hcl | $19 | $83861 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,108 psychiatry providers in North Carolina.
Other psychiatry in Charlotte
- Devendra ShahCharlotte$24K
- Oleg TcheremissineCharlotte$18K
- Kenneth RichmondCharlotte$15K
- Preetinder BrarCharlotte$13K
- Craig ChepkeHuntersville$4.1M
- Mark ReynoldsDurham$3.2M
- James BarkerHickory$2.1M
- Brian FarahWinston Salem$605K
- Krishna TalluriMorrisville$591K
- Ramesh GihwalaGastonia$545K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.